Updated May 4, 2026
Go to JCI Insight's conflict-of-interest policy
Alnylam (SP Monga)
American Heart Association (SY Chan)
Amgen (CR Kliment)
Antlera (SP Monga)
AstraZeneca (ME Snyder)
Bayer (SY Chan, TL Suber)
Bristol Myers Squibb (O Eickelberg)
Coloma Therapeutics (T Finkel)
Corcept Therapeutics (PK Fazeli)
Crinetics (PK Fazeli)
ED Soreno (HD Skinner)
Eli Lilly (EE Kershaw)
Fauna Bio (O Eickelberg)
Generian Pharmaceuticals (T Finkel)
Haemonetics (MD Neal)
Haima Therapeutics (MD Neal)
Immunetrics (TR Billiar)
Instrumentation Laboratories (MD Neal)
Pfizer (EE Kershaw)
Regeneron (EE Kershaw)
Santa Ana Bio (A Ray)
SeromYx Systems, Inc. (J Das)
Synhale Therapeutics (SY Chan)
Takeda (MD Neal)
United Therapeutics (SY Chan)
WoodNext Foundation (SY Chan)
